Nationwide Fund Advisors - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 76 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$283,000
+3.7%
38,428
-4.5%
0.00%0.0%
Q2 2017$273,000
-30.9%
40,235
-3.8%
0.00%
-50.0%
Q1 2017$395,000
+7.6%
41,813
-1.6%
0.00%0.0%
Q4 2016$367,000
+31.1%
42,505
-3.8%
0.00%
+100.0%
Q3 2016$280,000
+49.7%
44,2040.0%0.00%0.0%
Q2 2016$187,000
-3.1%
44,2040.0%0.00%0.0%
Q1 2016$193,000
-32.0%
44,204
-4.7%
0.00%0.0%
Q4 2015$284,000
+9.7%
46,383
+2.3%
0.00%0.0%
Q3 2015$259,000
-23.4%
45,3200.0%0.00%0.0%
Q2 2015$338,000
+11.2%
45,320
-10.9%
0.00%0.0%
Q1 2015$304,000
-24.9%
50,889
-4.9%
0.00%
-50.0%
Q4 2014$405,000
+43.6%
53,539
-1.4%
0.00%
+100.0%
Q3 2014$282,000
+20.5%
54,314
+0.2%
0.00%0.0%
Q2 2014$234,000
+8.8%
54,184
+3.3%
0.00%0.0%
Q1 2014$215,000
-13.0%
52,462
+13.4%
0.00%0.0%
Q4 2013$247,000
-32.1%
46,261
-36.0%
0.00%
-50.0%
Q3 2013$364,000
+33.3%
72,294
+18.1%
0.00%
+100.0%
Q2 2013$273,00061,2180.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
ARDSLEY ADVISORY PARTNERS LP 1,255,000$5,823,0001.12%
Phocas Financial Corp. 1,146,292$5,319,0000.54%
Worth Venture Partners, LLC 138,357$641,0000.36%
RICE HALL JAMES & ASSOCIATES, LLC 2,293,179$10,640,0000.34%
Monashee Investment Management LLC 240,000$1,114,0000.26%
BKS ADVISORS, LLC 118,587$550,0000.22%
PINNACLE ASSOCIATES LTD 1,418,391$6,581,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 4,200,820$19,492,0000.15%
Fosun International Ltd 472,580$2,174,0000.14%
CARILLON TOWER ADVISERS, INC. 3,948,024$18,318,0000.13%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders